Advancements in the Management of Aortic Stenosis: The Importance of Early Detection and Timely Treatment

A Special Issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425) belonging to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: 25 November 2026 | Viewed by 633

Editors


E-Mail Website
Guest Editor
Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
Interests: cardiology; precision medicine; residual risk; acute coronary syndrome; percutaneous coronary intervention; PCI
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor Assistant
1. Department of Medicine and Surgery, Università degli Studi di Enna “Kore”, 94100 Enna, Italy
2. Division of Cardiology, Ospedale Umberto I, ASP 4 di Enna, 94100 Enna, Italy
Interests: cardiology; interventional cardiology; left atrial appendage closure (LAAC); coronary artery disease; transcatheter aortic valve replacement (TAVR)

Special Issue Information

Dear Colleagues,

Severe aortic stenosis represents one of the most common and clinically relevant valvular heart diseases in the ageing population. For many years, access to transcatheter aortic valve replacement (TAVR) was limited by procedural risk, anatomical feasibility, and resource availability. However, the progressive increase in life expectancy has led to a growing prevalence of degenerative aortic valve disease, while the expansion of TAVR indications to younger patients and those at lower surgical risk has markedly increased referral volumes.

This evolution has been driven by major technological advancements. Newer-generation transcatheter valves have significantly improved procedural safety, reduced complication rates, and provided more favourable long-term outcomes. At the same time, advances in multimodality imaging and screening strategies are improving our ability to identify patients at higher risk of disease progression and to detect early myocardial damage before the onset of symptoms.

These developments highlight the importance of timely intervention and accurate patient selection. In particular, some clinical scenarios remain especially challenging in terms of optimal treatment timing and technical complexity, such as patients with severe asymptomatic aortic stenosis and those with bicuspid aortic valve anatomy.

This Special Issue aims to provide an updated overview of current advances in the diagnosis, risk stratification, and management of aortic stenosis, with a focus on early detection strategies, evolving indications for intervention, and the technical and clinical challenges associated with complex patient subsets. We welcome original research articles, reviews, and expert perspectives addressing advances in imaging, patient selection, transcatheter therapies, and long-term outcomes in the management of aortic stenosis.

Prof. Dr. Antonio Micari
Guest Editor

Dr. Giulia Laterra
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aortic stenosis
  • transcatheter aortic valve replacement
  • early intervention
  • risk stratification
  • bicuspid aortic valve
  • cardiac imaging

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 4162 KB  
Article
Clinical Outcomes and Factors Associated with MACCE in Chinese Patients Undergoing Single-Hospitalization PCI and Transfemoral TAVR
by Tong Tan, Alimujiang Awakeri, Hao Cui, Enjun Zhu and Yongqiang Lai
J. Cardiovasc. Dev. Dis. 2026, 13(8), 394; https://doi.org/10.3390/jcdd13080394 - 17 Aug 2026
Viewed by 301
Abstract
Background: The incidence and predictors of major adverse cardiovascular and cerebrovascular events (MACCE) in patients undergoing percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR) during the same hospitalization remain poorly characterized, particularly in Asian populations. Methods: This single-center retrospective study included [...] Read more.
Background: The incidence and predictors of major adverse cardiovascular and cerebrovascular events (MACCE) in patients undergoing percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR) during the same hospitalization remain poorly characterized, particularly in Asian populations. Methods: This single-center retrospective study included 164 consecutive patients who underwent PCI and transfemoral TAVR during the same hospitalization at Beijing Anzhen Hospital between June 2018 and October 2023. The primary objective was to evaluate the incidence of MACCE, and logistic regression analyses were used to identify its predictors. Results: Among 164 patients, the mean age was 73.9 ± 7.2 years, and 57.9% were male. Device success was 97.6% and procedural success was 89.6%. MACCE occurred in 28 patients (17.1%) within the index hospitalization or 30 days after discharge. Independent predictors of MACCE were lower baseline left ventricular ejection fraction (LVEF; OR = 0.955, 95% CI 0.920–0.992; p = 0.017) and mixed aortic stenosis and regurgitation (AS + AR; OR = 6.360, 95% CI 1.035–38.993; p = 0.038). Conclusions: A single-hospitalization PCI and TAVR strategy appeared feasible and was associated with acceptable short-term clinical outcomes in carefully selected Chinese candidates, with lower baseline LVEF and mixed AS and AR as independent predictors of MACCE. The observed clinical outcomes should be interpreted descriptively because of the lack of a contemporaneous comparator group; large-scale prospective studies are needed to further evaluate the safety and clinical benefit of this “one-stop” paradigm. Full article
Show Figures

Figure 1

Back to TopTop